Key Highlights
- Dr. Tom Grissom joins SHARx with over 26 years of clinical experience, previously founder and CEO at Algone Pain Intervention Clinic.
- Aims to enhance affordable access to lifesaving medications for the underinsured, tackling a major challenge in the American healthcare system.
- Dr. Grissom’s appointment underscores SHARx’s commitment to improving patient advocacy and support through expert leadership.
Source: Business Wire
Notable Quotes
- “One of the biggest challenges facing the American healthcare system is ensuring that patients have affordable access to the lifesaving and life-altering medications they need,” – Dr. Tom Grissom, MD, First Medical Director at SHARx
- “Patient advocacy is a calling for which Dr. Grissom has a passion that goes back decades, and by bringing that passion to SHARx, he will help us better serve our members,” – Corey Durbin, CEO at SHARx
SoH's Take
The appointment of Dr. Tom Grissom as SHARx’s first Medical Director is a significant stride towards bolstering the company’s mission to advocate for affordable access to crucial medications for the underinsured. His remarkable clinical background, combined with a deep-seated passion for patient advocacy, positions SHARx to significantly impact the healthcare landscape. This move not only highlights the growing importance of patient advocacy organizations in bridging healthcare gaps but also reflects a broader industry trend towards prioritizing patient access and affordability over profit. Dr. Grissom’s leadership is anticipated to drive SHARx towards new heights in its advocacy efforts, setting a commendable example for others in the healthcare sector.
